Amoy Diagnostics
Alercell to Distribute Amoy Diagnostic Ros1 Gene Fusion Detection Kit in US
The 14-fusion PCR assay for lung cancer subtyping is available for research-use only but will be more broadly distributed when the kits gain FDA clearance.
In Brief This Week: Labcorp, QuantuMDx, LumiraDx, Danaher, Thermo Fisher Scientific, and More
News items for the in vitro diagnostics industry for the week of Feb. 21, 2022.
Amoy Diagnostics, Pierre Fabre Collaborate to Develop CDx in China
The companion diagnostic kits will support marketing authorization applications for Pfizer's Braftovi and Mektovi.
Amoy Diagnostics, Amgen Partner on Lung Cancer CDx Development for Lumakras in Japan
Amoy Diagnostics will develop its PCR-based panel as a companion diagnostic in Japan to screen NSCLC patients for Amgen's KRAS G12C inhibitor.
Amoy Diagnostics CDx Gets Japanese Approval to ID NSCLC Patients Eligible for Tepmetko
The Japanese Ministry of Health, Labor, and Welfare has approved AmoyDx's PLC Panel for use in identifying NSCLC patients with MET exon 14 skipping alterations.
Nov 25, 2019
AmoyDx, Eisai Form CDx Development Alliance
Oct 12, 2018
AmoyDx Lung Cancer CDx Approved in South Korea
Jan 29, 2018
AmoyDx, Medikonia Ink MDx Distribution Deal
May 16, 2017